FMP
Nov 8, 2024 12:00 PM - Tony Dante
Image credit: Google Images
Canopy Growth Corporation, listed as NASDAQ:CGC, is a prominent player in the cannabis industry. The company focuses on producing and selling cannabis and cannabis-related products. It competes with other major cannabis companies like Aurora Cannabis and Tilray. On November 8, 2024, CGC reported its earnings, revealing an earnings per share (EPS) of -$1.09, which was significantly below the expected EPS of -$0.27.
Despite the disappointing EPS, CGC's revenue for the period was approximately $54.7 million, surpassing the estimated $47.2 million. This revenue growth is partly due to a 32% year-over-year increase in net revenue for its Storz & Bickel segment. Additionally, Canopy Growth's medical cannabis businesses have shown continued growth, with net revenue rising by 16% in Canada and 12% in international markets.
Financially, CGC faces challenges, as indicated by its negative price-to-earnings (P/E) ratio of -0.78. This suggests the company is not currently profitable. The price-to-sales ratio of 1.52 indicates that investors are paying $1.52 for every dollar of sales. The enterprise value to sales ratio is 2.79, providing insight into the company's valuation relative to its revenue.
The enterprise value to operating cash flow ratio is negative at -4.61, highlighting potential challenges in generating positive cash flow from operations. The earnings yield is also negative at -1.28%, further reflecting the company's current unprofitability. However, CGC has strengthened its balance sheet by making an early prepayment, reducing its senior secured term loan by $100 million USD.
The debt-to-equity ratio of 1.09 indicates that CGC has slightly more debt than equity. The current ratio of 1.39 suggests that Canopy Growth Corporation has a reasonable level of liquidity to cover its short-term liabilities. This financial position provides some stability as the company navigates its profitability challenges.
Nov 22, 2024 5:08 AM - Parth Sanghvi
Fundamental analysis is one of the most essential tools for investors and analysts alike, helping them assess the intrinsic value of a stock, company, or even an entire market. It focuses on the financial health and economic position of a company, often using key data such as earnings, expenses, ass...
Dec 17, 2024 8:58 AM - Sanzhi Kobzhan
Tesla, one of the world’s most talked-about electric vehicle manufacturers, attracts a lot of attention from investors and market watchers. By examining a snapshot of Tesla’s financial ratios—such as those provided by FinancialModelingPrep’s Ratios API—we can get a clearer picture of the company’s f...
Dec 22, 2024 7:59 AM - Sanzhi Kobzhan
When it comes to cutting-edge software and data analytics, Palantir Technologies (NYSE: PLTR) is often front and center. But for many investors, it’s important to consider alternative or complementary stocks in the same sector that may offer robust growth potential. As PLTR looks expensive (overvalu...